Articles

Contact Us Contact Us

1.800.553.9910

Consumer Alert: Fosamax May Cause Osteonecrosis ("Jaw Death")

If you or someone you know has taken Fosamax and has suffered jaw injuries, you may wish to email us..

Email Us

You must read the following notice before sending an e-mail message to Robins, Kaplan, Miller & Ciresi L.L.P.

Any information that you send us in an e-mail message should not be confidential or otherwise privileged information. Sending us an e-mail message will not make you a client of Robins, Kaplan, Miller & Ciresi L.L.P. We do not accept representation until we have had an opportunity to evaluate your matter, including but not limited to an ethical evaluation of whether we are in a conflict position to represent you. Accordingly, the information you provide to us in an e-mail should not be information for which you would have an expectation of confidentiality.

If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.

By continuing to the next step, you are confirming that you have read and understood this important notice.

Spring 2012 Update
Our attorneys are actively litigating cases in the Fosamax jaw injury MDL in New York and in the recently-established Fosamax femur fracture MDL in New Jersey. Read more.

Spring 2011 Update
On October 13, 2010, the FDA issued a warning to physicians caring for patients taking FOSAMAX noting that all FOSAMAX and other bisphosphonates have been associated with atypical fractures to the femur. Read more.

April 8, 2011 Update
Thousands of Americans have been taking the prescription drug FOSAMAX® for treatment and prevention of osteopenia and osteoporosis.  According to the Office of the Surgeon General, in 2004, over 10 millions Americans over the age of 50 were diagnosed with osteoporosis of the hip joint alone, and the prevalence of osteoporosis is expected to rise dramatically as the population continues to age. Read more.

April 12, 2006 - Fosamax is a medicine in the bisphosphonates family that is prescribed widely to prevent bone loss or the decrease of bone density. It is commonly used by post-menopausal women. There have been reports that persons taking Fosamax have developed a severe problem in which bone in their jaws dies. This “jaw death” (also referred to jaw necrosis or jaw decay) often appears after minor trauma such as a tooth extraction. According to press reports, the American Association of Endodontists recently released a position paper that cautions that many patients who take Fosamax may be at risk this terrible complication. Other bisphosphonates such as Actonel may also be implicated.

If you or someone you know has taken Fosamax and has suffered jaw injuries, you may wish to contact us. Please call Gary Wilson or Tara Sutton at 612-349-8500 or e-mail them at this link: contact us.

Related Links

The articles on our Web site include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice or as an expression of the views of the firm, its attorneys or any of its clients. We hope the articles spur discussion in the legal community with insight into the experience of the authors. We expressly reserve the right in the future to become wiser or simply change our mind.

My Pages

Sign up for email updates and track your favorite web pages